跳至主要内容
临床试验/JPRN-UMIN000032281
JPRN-UMIN000032281已完成未知

Multi-center randomized controlled blind study of LC-4308 in Distal Radius Fracture patients treated with Volar Locking Plate scheduled to be removed - Multi-center randomized controlled blind study of LC-4308

JMS CO.,LTD.0 个研究点目标入组 80 人开始时间: 2018年4月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
JMS CO.,LTD.
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Patients with an open fracture in the target site (2)Patients complicated by other site fractures which may influence the evaluation of end points (3)Patients with the possibility of the rupture of tendon, main nerve, or blood vessels in the target site (4)Patients with the possibility of the combination of Artificial bones (5)Patients with the possibility of the placement of the locking plate beyond the watershed line (6)Patients unable to follow the instruction of rehabilitation (7)Patients who have limited range of motion of either one or both thumbs (8)Patients with high risk of fracture from the continuous treatment of oral steroids (9)Patients with serious Cardiovascular diseases, Liver diseases, Respiratory diseases, Malignancy or Immunodeficiency at registration (10)Patients with a history of severe drug allergies (11)Patients with a history of Biodegradable plastic allergies (12)Uncontrollable Diabetes mellitus (13)Patients with pregnancy or possible pregnancy, patients who are breast-feeding, and patients who cannot prevent pregnancy properly until locking plate removal after informed consent (14)Patients with Rheumatoid arthritis (15)Patients who are continuing to undergo or have not yet finished their tests or other clinical studies under informed consent (16)Others, patients who are judged as inadequately by principal investigator or sub-investigator

研究者

发起方
JMS CO.,LTD.

相似试验

进行中(未招募)
1 期
A research study to find out if aprocitentan is efficacious and safe to treat patients with uncontrolled blood pressure and chronic kidney diseaseHypertension
EUCTR2018-003819-22-LVIdorsia Pharmaceuticals Ltd200
进行中(未招募)
1 期
A research study to find out if aprocitentan is efficacious and safe to treat patients with uncontrolled blood pressure and chronic kidney diseaseHypertension
EUCTR2018-003819-22-ESIdorsia Pharmaceuticals Ltd200
进行中(未招募)
1 期
A research study to find out if aprocitentan is efficacious and safe to treat patients with uncontrolled blood pressure and chronic kidney diseaseHypertension
EUCTR2018-003819-22-CZIdorsia Pharmaceuticals Ltd200
进行中(未招募)
1 期
A research study to find out if aprocitentan is efficacious and safe to treat patients with uncontrolled blood pressure and chronic kidney diseaseHypertension
EUCTR2018-003819-22-HUIdorsia Pharmaceuticals Ltd200
进行中(未招募)
1 期
A randomized study comparing two types of muscle relaxants regarding the influence on tracheal intubation during anaesthesia in elderly patients (= 80 years old)The aim of this study is to determine the proportion of excellent tracheal intubation conditions at 60 seconds after administration of either rocuronium 1.0 mg/kg or suxamethonium 1 mg/kg in patients with age = 80 years.MedDRA version: 23.1Level: LLTClassification code 10051079Term: Orthopedic procedureSystem Organ Class: 100000004865MedDRA version: 20.0Level: LLTClassification code 10000082Term: Abdominal pain generalisedSystem Organ Class: 100000004856
EUCTR2020-005384-31-DKRigshospitalet90